Navigation Links
Vision Therapy Expert Announces Vision Therapy Best Treatment for Amblyopia
Date:6/27/2012

Gainesville, VA (PRWEB) June 27, 2012

According to the Bostons Children Hospital one in 50 or 2% of children develop a vision disorder called amblyopia, or “lazy eye”, undetected by standard eye examinations. Corrective lenses won’t treat the problem, but research indicates vision therapy can.

That’s why Dr. Tod Davis, a developmental optometrist with more than 30 years of clinical experience, recommends parents have their children screened for this disorder, and also exhorts them to have themselves screened if they had not been in the past. “There is a prevailing myth that you must catch amblyopia before the age of six in order for meaningful correction to be possible,” Dr. Davis says. “However, the truth is that this disorder is correctable at any age. We have had success with adults as well as children with our vision therapy methods.”

Amblyopia, not to be confused with crossed eyes, occurs when the brain fails to recognize the images received by one of the eyes. When one eye sees clearly and the other does not, the brain learns to ignore the eye with blurred vision and loss of vision occurs. Anything that interferes with vision may result in amblyopia. Untreated children run a greater risk of losing vision in the good eye.

“Children with this amblyopia often have problems with depth perception and seeing detail,” Dr. Davis said. “This is one of those eye disorders that can’t be treated with eyeglasses; fortunately, our vision therapy programs offer a high success rate of restoring normal eyesight. The earlier amblyopia is detected, the faster we can begin to treat it.”

Dr. Davis’ vision therapy begins with a thorough eye examination that determines how well the eyes work together. This examination goes beyond the standard eye chart assessment to evaluate how the eyes work up close and together, as well as how they move and how often they reverse letters or words. If someone is diagnosed with amblyopia, Dr. Davis creates an individualized therapy program designed to enhance the brain’s ability to control eye alignment, teaming, focusing, tracking and visual processing. Therapy typically lasts anywhere from six months to one year, with significant improvement taking place within the first four months.

About Dr. Tod Davis
Dr. Tod Davis Developmental Optometry and Vision Therapy Services offices are located in Gainesville, Fredericksburg and Winchester, Va. Dr. Davis is a developmental optometrist with over 30 years of experience treating people of all ages for a spectrum of different vision disorders, including convergence insufficiency, strabismus, amblyopia and vision-related reading difficulties. Visit DavisVisionTherapy.com for more information, patient forms and contact information.

Read the full story at http://www.prweb.com/releases/vision-therapy-dr-davis/lazy-eye-amblyopia/prweb9469669.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. VisionWare and Serco Partner to Enable ‘Digital by Default’ Strategy
2. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
3. Oakworks Medical, a Division of Oakworks Inc., Oakworks.com, Manufacturer of Medical Tables and Positioning Devices Announces ISO 13485 Certification
4. Fatty acid found in fish prevents age-related vision loss: U of A medical research
5. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
6. Can a standard vision test predict nighttime driving performance?
7. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
8. Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence
9. Study suggests touch therapy helps reduce pain, nausea in cancer patients
10. Intensive cholesterol therapy with multiple drugs effective over long term
11. U.S.A. Hurdle Specialist Kellie Wells has Joined Elite Athletes Tiger Woods, Hines Ward and Takaishi Saito in Using Cell Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Crossover Symmetry , an evidence based ... lifestyle company that provides Human Performance Training and education to tactical athletes. Together ... military officers and others in service through the development and conditioning of overall ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical ... Care Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual ... healthcare providers an opportunity to learn about cutting edge treatments, to collaborate, share ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a ... Care of Utah (APCUT) and has appointed Rex Wheeler as its new Director of ... for our agency and our ability to provide quality care to the community,” said ...
(Date:4/21/2017)... ... , ... During April 21-23, Super-Sod will join the vendor market of the ... everyone — from the avid gardener to the landscape admirer — during the three-day ... in a grand venue, and we are certainly looking forward to participating in this ...
(Date:4/21/2017)... ... April 21, 2017 , ... National pest management association survey conducted ... of bed bug infestations over the 5-year period. In 2015 10% or US$750 million ... of bed bug infested properties. , The health and economic consequences of bed ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
Breaking Medicine Technology: